Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
07:00am, Wednesday, 14'th Sep 2022
NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous syste
3 Growth Stocks That Are Crushing It This Year
02:45pm, Saturday, 10'th Sep 2022 The Motley Fool
These three biotech companies have bucked the trend of declining shares prices in their sector.
2 Top Biotech Stocks Defying the Bear Market
02:30pm, Saturday, 10'th Sep 2022 The Motley Fool
Both could see record sales throughout the next few years.
3 Growth Stocks That Are Crushing It This Year
10:45am, Saturday, 10'th Sep 2022
These three biotech companies have bucked the trend of declining shares prices in their sector.
2 Top Biotech Stocks Defying the Bear Market
10:30am, Saturday, 10'th Sep 2022
Both could see record sales throughout the next few years.
Axsome (AXSM) Initiates Late-Stage Alzheimer's Agitation Study
04:18pm, Friday, 09'th Sep 2022 Zacks Investment Research
Axsome Therapeutics (AXSM) enrolls the first patient in a late-stage study of AXS-05 for Alzheimer's disease agitation.
Is Axsome Therapeutics a Buy?
02:53pm, Friday, 09'th Sep 2022 The Motley Fool
Its near-term outlook is quite rosy, but there is also a risk it might not meet investors' hopes.
Axsome (AXSM) Initiates Late-Stage Alzheimer's Agitation Study
01:33pm, Friday, 09'th Sep 2022
Axsome Therapeutics (AXSM) enrolls the first patient in a late-stage study of AXS-05 for Alzheimer's disease agitation.
Is Axsome Therapeutics a Buy?
10:53am, Friday, 09'th Sep 2022
Its near-term outlook is quite rosy, but there is also a risk it might not meet investors' hopes.
Why Is Axsome (AXSM) Up 26.9% Since Last Earnings Report?
03:30pm, Thursday, 08'th Sep 2022 Zacks Investment Research
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Axsome (AXSM) Up 26.9% Since Last Earnings Report?
12:47pm, Thursday, 08'th Sep 2022
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
10:20am, Thursday, 08'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for XPH
Mizuho Bolsters Price Target By 55% On This Migraine Stock
07:14pm, Wednesday, 07'th Sep 2022 Benzinga
Mizuho Securities assumes coverage of Axsome Therapeutics Inc (NASDAQ: AXSM), with a Buy rating and a price target of $76, representing a 25% upside from the last close is 55% above the initial pr
Axsome (AXSM) up 118.4% in the Past Three Months: Here's Why
12:02pm, Tuesday, 06'th Sep 2022
Axsome (AXSM) surges in the past three months owing to its Sunosi acquisition and promising progress on its pipeline candidate.
Nasdaq Bear Market: 2 Top Growth Stocks You'll Wish You'd Bought on the Dip
05:47am, Monday, 05'th Sep 2022
These stocks are poised for a strong rebound once the ongoing bear market turns bullish again.
